References
  1. Biederman J, Krishnan S, Zhang Y, et al. Efficacy and safety of lisdexamfetamine dimesylate (LDX; NPR 104) in children with attention-deficit/hyperactivity disorder: a phase 3, randomized, multicenter, double-blind, parallel-group study. Clin Ther. 2007 29:450-463.
  2. Vyvanse [package insert], Wayne, Pa: Shire US Inc., 2007.
  3. Data on file; LDX009; Shire US Inc.
  4. Data on file; LDX008; Shire US Inc.
 
© 2008 Shire US Inc Wayne, PA 19087-5637 (800) 828-2088. All Rights reserved. This site is strictly intended for U.S. residents and is governed solely by U.S. laws and governmental regulations. Please see our online privacy policy for more information. While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. assumes no liability for any errors or ommissions in the content of the site.

LDX2005 | 04/08